ResMed
Prezzo: 194.78Società e modello di business
ResMed is a healthcare company specializing in cloud-connected devices and software solutions for people with sleep apnea and chronic obstructive pulmonary disease (COPD). Its core products include continuous positive airway pressure (CPAP) devices, masks, and cloud-based software for patient management. The company operates primarily in the sleep and respiratory care segments, with major revenue sources stemming from device sales, software subscriptions, and related accessories.
Profilo di investimento
The investment profile of ResMed is more aligned with balanced investors, given its moderate growth potential and dividend yield. The company offers a steady revenue stream while also providing some income through dividends. However, the elevated risk factors suggest caution for those seeking aggressive growth.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- 10.38 OK
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- 0.6% ≈
- Sorpresa EPS
- 2.5% in linea
- Volatilità 20g
- 2.1% stabile
- Rendimento dividendo
- 1.3% moderato ultima data ex-dividendo: 2026-05-14
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-06-03 02:51 | Mantieni | Vendi | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:49 | Vendi | Mantieni | Weak momentum and mixed fundamentals suggest caution. |
| 2026-05-08 15:18 | — | Vendi | Weak momentum and high risk overshadow potential upside. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-05-01 12:52 | Robert W. Baird | Target abbassato | 254 → 225 | 203.87 |
| 2026-04-27 10:21 | KeyBanc | Target abbassato | 302 → 290 | 219.85 |
| 2026-04-13 14:44 | Evercore ISI | Target abbassato | 300 → 255 | 228.33 |
Ancora nulla